» Authors » Anna Savitskaya

Anna Savitskaya

Explore the profile of Anna Savitskaya including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 47
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Savitskaya A, Masso-Silva J, Haddaoui I, Enany S
Biochimie . 2023 Jul; 214(Pt B):216-227. PMID: 37499896
Antimicrobial peptides (AMPs) are essential for defence against pathogens in all living organisms and possessed activities against bacteria, fungi, viruses, parasites and even cancer cells. AMPs are short peptides containing...
2.
Ilinov A, Nishiyama A, Namba H, Fukushima Y, Takihara H, Nakajima C, et al.
Sci Rep . 2021 May; 11(1):10953. PMID: 34040029
DNA is basically an intracellular molecule that stores genetic information and carries instructions for growth and reproduction in all cellular organisms. However, in some bacteria, DNA has additional roles outside...
3.
Savitskaya A, Nishiyama A, Yamaguchi T, Tateishi Y, Ozeki Y, Nameta M, et al.
Sci Rep . 2018 May; 8(1):8197. PMID: 29844400
The architecture of the genome influences the functions of DNA from bacteria to eukaryotes. Intrinsically disordered regions (IDR) of eukaryotic histones have pivotal roles in various processes of gene expression....
4.
Enany S, Yoshida Y, Tateishi Y, Ozeki Y, Nishiyama A, Savitskaya A, et al.
Sci Rep . 2017 Jul; 7(1):6810. PMID: 28754952
Bacteria can proliferate perpetually without ageing, but they also face conditions where they must persist. Mycobacteria can survive for a long period. This state appears during mycobacterial diseases such as...
5.
Muharemagic D, Zamay A, Ghobadloo S, Evgin L, Savitskaya A, Bell J, et al.
Mol Ther Nucleic Acids . 2014 Jun; 3:e167. PMID: 24892725
Oncolytic viruses promise to significantly improve current cancer treatments through their tumor-selective replication and multimodal attack against cancer cells. However, one of the biggest setbacks for oncolytic virus therapy is...